var eventsData = [{"Ticker":"MYL","EffectiveDate":"2017-01-05","Type":"RatingNeutral","Title":"Citigroup downgrades MYL to Neutral from Buy. Target Price is $44; previously $59.","DailyReturn":-0.01186,"FiveDayReturnAfter":-0.061131,"FiveDayReturnBefore":0.053115},{"Ticker":"MYL","EffectiveDate":"2016-11-09","Type":"EarningsRevenueMiss","Title":"After market close, MYL reports 2016 Q3's earning $1.38 per share and revenue $3057MM. This misses analyst's estimated EPS $1.45, misses estimated revenue $3120MM.","DailyReturn":0.048774,"FiveDayReturnAfter":0.040919,"FiveDayReturnBefore":-0.001347},{"Ticker":"MYL","EffectiveDate":"2016-10-25","Type":"RatingNeutral","Title":"Mizuho initiates coverage on MYL to Buy.","DailyReturn":0.029819,"FiveDayReturnAfter":-0.028628,"FiveDayReturnBefore":0.030274},{"Ticker":"MYL","EffectiveDate":"2016-10-10","Type":"RatingUpgrade","Title":"Raymond James upgrades MYL to Strong Buy from Market Perform.","DailyReturn":0.081525,"FiveDayReturnAfter":0.015188,"FiveDayReturnBefore":-0.058887},{"Ticker":"MYL","EffectiveDate":"2016-09-30","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $45; previously $55.","DailyReturn":-0.009098,"FiveDayReturnAfter":-0.043294,"FiveDayReturnBefore":-0.101741},{"Ticker":"MYL","EffectiveDate":"2016-09-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains MYL to Buy. Target Price is $58; previously $60.","DailyReturn":-0.012444,"FiveDayReturnAfter":-0.101741,"FiveDayReturnBefore":0.026167},{"Ticker":"MYL","EffectiveDate":"2016-08-15","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $55; previously $51.","DailyReturn":0.005984,"FiveDayReturnAfter":0.004118,"FiveDayReturnBefore":0.0},{"Ticker":"MYL","EffectiveDate":"2016-08-09","Type":"EarningsBeatRevenueMiss","Title":"After market close, MYL reports 2016 Q2's earning $1.16 per share and revenue $2561MM. This beats analyst's estimated EPS $1.14, misses estimated revenue $2570MM.","DailyReturn":0.028642,"FiveDayReturnAfter":0.004523,"FiveDayReturnBefore":0.037581},{"Ticker":"MYL","EffectiveDate":"2016-05-04","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $51; previously $53.","DailyReturn":-0.040055,"FiveDayReturnAfter":-0.068192,"FiveDayReturnBefore":-0.029321},{"Ticker":"MYL","EffectiveDate":"2016-02-19","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on MYL to Market Perform.","DailyReturn":0.014091,"FiveDayReturnAfter":0.058848,"FiveDayReturnBefore":-0.122568},{"Ticker":"MYL","EffectiveDate":"2016-02-19","Type":"RatingNeutral","Title":"Argus Research maintains MYL to Buy. Target Price is $55; previously $65.","DailyReturn":0.014091,"FiveDayReturnAfter":0.058848,"FiveDayReturnBefore":-0.122568},{"Ticker":"MYL","EffectiveDate":"2016-02-16","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $50; previously $53.","DailyReturn":0.031556,"FiveDayReturnAfter":0.112483,"FiveDayReturnBefore":-0.205829},{"Ticker":"MYL","EffectiveDate":"2015-12-17","Type":"RatingNeutral","Title":"Goldman Sachs maintains MYL to Buy.","DailyReturn":-0.026108,"FiveDayReturnAfter":0.007328,"FiveDayReturnBefore":0.070254},{"Ticker":"MYL","EffectiveDate":"2015-12-03","Type":"RatingNeutral","Title":"Morgan Stanley assumes MYL to Equal-Weight. Target Price is $56.","DailyReturn":-0.019393,"FiveDayReturnAfter":-0.026855,"FiveDayReturnBefore":0.03299},{"Ticker":"MYL","EffectiveDate":"2015-11-02","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $53; previously $60.","DailyReturn":0.039011,"FiveDayReturnAfter":0.019539,"FiveDayReturnBefore":0.073636},{"Ticker":"MYL","EffectiveDate":"2015-10-30","Type":"EarningsBeatRevenueMiss","Title":"After market close, MYL reports 2015 Q3's earning $1.43 per share and revenue $2712MM. This beats analyst's estimated EPS $1.38, misses estimated revenue $2780MM.","DailyReturn":-0.036916,"FiveDayReturnAfter":-0.021864,"FiveDayReturnBefore":0.156191},{"Ticker":"MYL","EffectiveDate":"2015-09-21","Type":"RatingNeutral","Title":"Barclays initiates coverage on MYL to Equal-Weight. Target Price is $57.","DailyReturn":-0.028836,"FiveDayReturnAfter":-0.128503,"FiveDayReturnBefore":0.019137},{"Ticker":"MYL","EffectiveDate":"2015-08-26","Type":"RatingNeutral","Title":"Standpoint Research initiates coverage on MYL to Buy. Target Price is $70.","DailyReturn":0.041132,"FiveDayReturnAfter":-0.016838,"FiveDayReturnBefore":-0.126816},{"Ticker":"MYL","EffectiveDate":"2015-07-27","Type":"RatingNeutral","Title":"Cowen & Co. downgrades MYL to Market Perform from Outperform.","DailyReturn":-0.145132,"FiveDayReturnAfter":-0.163572,"FiveDayReturnBefore":-0.03765},{"Ticker":"MYL","EffectiveDate":"2015-06-18","Type":"RatingNeutral","Title":"BTIG Research initiates coverage on MYL to Buy. Target Price is $85.","DailyReturn":0.018672,"FiveDayReturnAfter":-0.00521,"FiveDayReturnBefore":-0.038961},{"Ticker":"MYL","EffectiveDate":"2015-06-12","Type":"RatingNeutral","Title":"Citigroup maintains MYL to Neutral. Target Price is $75.","DailyReturn":-0.005532,"FiveDayReturnAfter":-0.021136,"FiveDayReturnBefore":-0.002425},{"Ticker":"MYL","EffectiveDate":"2015-06-03","Type":"RatingNeutral","Title":"Raymond James initiates coverage on MYL to Market Perform.","DailyReturn":0.001522,"FiveDayReturnAfter":0.020812,"FiveDayReturnBefore":0.024226},{"Ticker":"MYL","EffectiveDate":"2015-04-22","Type":"RatingNeutral","Title":"CRT Capital maintains MYL to Buy. Target Price is $87; previously $68.","DailyReturn":-0.022546,"FiveDayReturnAfter":-0.01853,"FiveDayReturnBefore":0.076427},{"Ticker":"MYL","EffectiveDate":"2015-04-21","Type":"RatingUpgrade","Title":"BMO Capital upgrades MYL to Market Perform from Underperform. Target Price is $75; previously $41.","DailyReturn":0.088464,"FiveDayReturnAfter":0.052528,"FiveDayReturnBefore":-0.007466},{"Ticker":"MYL","EffectiveDate":"2015-04-13","Type":"RatingNeutral","Title":"Deutsche Bank maintains MYL to Buy. Target Price is $65; previously $62.","DailyReturn":-0.023918,"FiveDayReturnAfter":-0.005997,"FiveDayReturnBefore":0.189751},{"Ticker":"MYL","EffectiveDate":"2015-04-08","Type":"RatingNeutral","Title":"JP Morgan maintains MYL to Overweight. Target Price is $70; previously $66.","DailyReturn":0.147558,"FiveDayReturnAfter":0.141431,"FiveDayReturnBefore":-0.007193},{"Ticker":"MYL","EffectiveDate":"2015-03-23","Type":"RatingNeutral","Title":"CRT Capital maintains MYL to Buy. Target Price is $68; previously $60.","DailyReturn":0.003489,"FiveDayReturnAfter":-0.022938,"FiveDayReturnBefore":0.053749},{"Ticker":"MYL","EffectiveDate":"2015-03-06","Type":"RatingNeutral","Title":"Susquehanna maintains MYL to Positive. Target Price is $68; previously $60.","DailyReturn":-0.02205,"FiveDayReturnAfter":0.094363,"FiveDayReturnBefore":-0.009831},{"Ticker":"MYL","EffectiveDate":"2015-03-05","Type":"RatingNeutral","Title":"Morgan Stanley assumes MYL to Overweight. Target Price is $67.","DailyReturn":0.019421,"FiveDayReturnAfter":0.059174,"FiveDayReturnBefore":-0.015879},{"Ticker":"MYL","EffectiveDate":"2015-01-15","Type":"RatingNeutral","Title":"Deutsche Bank maintains MYL to Buy. Target Price is $62; previously $67.","DailyReturn":-0.033889,"FiveDayReturnAfter":-0.002752,"FiveDayReturnBefore":-0.027462},{"Ticker":"MYL","EffectiveDate":"2014-09-04","Type":"RatingNeutral","Title":"ISI Group initiates coverage on MYL.","DailyReturn":-0.018197,"FiveDayReturnAfter":-0.00777,"FiveDayReturnBefore":-0.010197},{"Ticker":"MYL","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"Citigroup maintains MYL to Neutral. Target Price is $54; previously $57.","DailyReturn":-0.013766,"FiveDayReturnAfter":-0.00734,"FiveDayReturnBefore":-0.060105},{"Ticker":"MYL","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"Keefe Bruyette & Woods maintains MYL to Outperform. Target Price is $55; previously $60.","DailyReturn":-0.013766,"FiveDayReturnAfter":-0.00734,"FiveDayReturnBefore":-0.060105},{"Ticker":"MYL","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"RBC Capital downgrades MYL to Sector Perform from Outperform. Target Price is $53; previously $60.","DailyReturn":-0.013766,"FiveDayReturnAfter":-0.00734,"FiveDayReturnBefore":-0.060105},{"Ticker":"MYL","EffectiveDate":"2014-07-25","Type":"RatingNeutral","Title":"Citigroup downgrades MYL to Neutral from Buy. Target Price is $57; previously $61.","DailyReturn":-0.003083,"FiveDayReturnAfter":-0.049976,"FiveDayReturnBefore":0.009096},{"Ticker":"MYL","EffectiveDate":"2014-07-15","Type":"RatingNeutral","Title":"JP Morgan maintains MYL to Overweight. Target Price is $68; previously $65.","DailyReturn":0.01815,"FiveDayReturnAfter":0.002921,"FiveDayReturnBefore":0.013358},{"Ticker":"MYL","EffectiveDate":"2014-06-11","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on MYL to Outperform.","DailyReturn":0.009346,"FiveDayReturnAfter":0.029626,"FiveDayReturnBefore":-0.013721},{"Ticker":"MYL","EffectiveDate":"2014-05-05","Type":"RatingNeutral","Title":"Leerink Swann maintains MYL to Outperform. Target Price is $57; previously $58.","DailyReturn":0.001405,"FiveDayReturnAfter":-0.076736,"FiveDayReturnBefore":-0.044748},{"Ticker":"MYL","EffectiveDate":"2014-04-07","Type":"RatingUpgrade","Title":"Citigroup upgrades MYL to Buy from Neutral. Target Price is $61; previously $52.","DailyReturn":-0.044045,"FiveDayReturnAfter":-0.102009,"FiveDayReturnBefore":0.036199},{"Ticker":"MYL","EffectiveDate":"2014-04-04","Type":"RatingUpgrade","Title":"Citigroup upgrades MYL to Buy from Neutral.","DailyReturn":0.015443,"FiveDayReturnAfter":-0.057584,"FiveDayReturnBefore":0.026007},{"Ticker":"MYL","EffectiveDate":"2014-03-28","Type":"RatingNeutral","Title":"Citigroup maintains MYL to Neutral. Target Price is $52; previously $42.","DailyReturn":0.005146,"FiveDayReturnAfter":0.026007,"FiveDayReturnBefore":-0.079695},{"Ticker":"MYL","EffectiveDate":"2014-02-28","Type":"RatingNeutral","Title":"Needham downgrades MYL to Hold from Buy. Target Price is $40.","DailyReturn":-0.01244,"FiveDayReturnAfter":-0.031227,"FiveDayReturnBefore":0.073929},{"Ticker":"MYL","EffectiveDate":"2014-02-27","Type":"EarningBeat","Title":"Before market open, MYL reports 2013 Q4's earning $0.78 per share and revenue $1810MM. This beats analyst's estimated EPS $0.75, meets estimated revenue $1810MM.","DailyReturn":0.094321,"FiveDayReturnAfter":0.082463,"FiveDayReturnBefore":0.005264},{"Ticker":"MYL","EffectiveDate":"2014-01-06","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on MYL to Outperform. Target Price is $50.","DailyReturn":-0.010768,"FiveDayReturnAfter":0.073322,"FiveDayReturnBefore":-0.002338},{"Ticker":"MYL","EffectiveDate":"2013-10-31","Type":"EarningsBeatRevenueMiss","Title":"Before market open, MYL reports 2013 Q3's earning $0.82 per share and revenue $1770MM. This beats analyst's estimated EPS $0.79, misses estimated revenue $1850MM.","DailyReturn":-0.014059,"FiveDayReturnAfter":0.028236,"FiveDayReturnBefore":-0.005711},{"Ticker":"MYL","EffectiveDate":"2013-10-25","Type":"RatingNeutral","Title":"Citigroup initiates coverage on MYL to Neutral. Target Price is $42.","DailyReturn":-0.001559,"FiveDayReturnAfter":-0.016239,"FiveDayReturnBefore":-0.031206},{"Ticker":"MYL","EffectiveDate":"2013-10-14","Type":"RatingNeutral","Title":"Morgan Stanley downgrades MYL to Equal-weight from Overweight; previously $41.","DailyReturn":-0.010774,"FiveDayReturnAfter":-0.034671,"FiveDayReturnBefore":-0.008482},{"Ticker":"MYL","EffectiveDate":"2013-09-12","Type":"RatingNeutral","Title":"Goldman Sachs maintains MYL to Buy. Target Price is $46; previously $40.","DailyReturn":0.017608,"FiveDayReturnAfter":0.014352,"FiveDayReturnBefore":0.057328},{"Ticker":"MYL","EffectiveDate":"2013-09-10","Type":"RatingUpgrade","Title":"Bernstein upgrades MYL to Outperform from Market Perform. Target Price is $44; previously $35.","DailyReturn":0.047958,"FiveDayReturnAfter":0.065241,"FiveDayReturnBefore":0.032023},{"Ticker":"MYL","EffectiveDate":"2013-08-05","Type":"RatingUpgrade","Title":"Buckingham Research upgrades MYL to Buy from Neutral.","DailyReturn":0.013187,"FiveDayReturnAfter":0.021472,"FiveDayReturnBefore":0.085115},{"Ticker":"MYL","EffectiveDate":"2013-08-02","Type":"RatingNeutral","Title":"UBS maintains MYL to Buy. Target Price is $39; previously $36.","DailyReturn":0.071218,"FiveDayReturnAfter":0.086496,"FiveDayReturnBefore":0.041767},{"Ticker":"MYL","EffectiveDate":"2013-08-02","Type":"RatingUpgrade","Title":"Cowen & Co. upgrades MYL to Outperform from Market Perform. Target Price is $45; previously $29.","DailyReturn":0.071218,"FiveDayReturnAfter":0.086496,"FiveDayReturnBefore":0.041767},{"Ticker":"MYL","EffectiveDate":"2013-08-02","Type":"RatingNeutral","Title":"Needham downgrades MYL to Buy from Strong Buy. Target Price is $40; previously $33.","DailyReturn":0.071218,"FiveDayReturnAfter":0.086496,"FiveDayReturnBefore":0.041767},{"Ticker":"MYL","EffectiveDate":"2013-08-02","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades MYL to Overweight from Equal-Weight. Target Price is $41.","DailyReturn":0.071218,"FiveDayReturnAfter":0.086496,"FiveDayReturnBefore":0.041767},{"Ticker":"MYL","EffectiveDate":"2013-08-01","Type":"EarningsBeatRevenueMiss","Title":"Before market open, MYL reports 2013 Q2's earning $0.68 per share and revenue $1700MM. This beats analyst's estimated EPS $0.67, misses estimated revenue $1730MM.","DailyReturn":0.012515,"FiveDayReturnAfter":0.099742,"FiveDayReturnBefore":0.035794},{"Ticker":"MYL","EffectiveDate":"2013-06-05","Type":"RatingNeutral","Title":"JP Morgan maintains MYL to Overweight. Target Price is $38; previously $34.","DailyReturn":0.00067,"FiveDayReturnAfter":0.029685,"FiveDayReturnBefore":-0.057252},{"Ticker":"MYL","EffectiveDate":"2013-05-10","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on MYL to Underperform. Target Price is $21.","DailyReturn":0.012983,"FiveDayReturnAfter":0.0477,"FiveDayReturnBefore":0.015146},{"Ticker":"MYL","EffectiveDate":"2013-05-02","Type":"RevenueBeat","Title":"After market close, MYL reports 2013 Q1's earning $0.62 per share and revenue $1630MM. This meets analyst's estimated EPS $0.62, misses estimated revenue $1690MM.","DailyReturn":0.00453,"FiveDayReturnAfter":0.021714,"FiveDayReturnBefore":0.000348},{"Ticker":"MYL","EffectiveDate":"2013-04-02","Type":"RatingNeutral","Title":"Canaccord Genuity maintains MYL to Hold. Target Price is $32; previously $33.","DailyReturn":-0.003484,"FiveDayReturnAfter":-0.011563,"FiveDayReturnBefore":-0.038283},{"Ticker":"MYL","EffectiveDate":"2013-03-25","Type":"RatingNeutral","Title":"Bernstein downgrades MYL to Market Perform from Outperform. Target Price is $33.","DailyReturn":-0.018444,"FiveDayReturnAfter":-0.038283,"FiveDayReturnBefore":-0.021563},{"Ticker":"MYL","EffectiveDate":"2013-03-11","Type":"RatingNeutral","Title":"Canaccord Genuity downgrades MYL to Hold from Buy. Target Price is $33.","DailyReturn":0.001302,"FiveDayReturnAfter":-0.008496,"FiveDayReturnBefore":0.020714},{"Ticker":"MYL","EffectiveDate":"2013-03-04","Type":"RatingNeutral","Title":"Bank of America maintains MYL to Buy. Target Price is $34; previously $33.","DailyReturn":0.02093,"FiveDayReturnAfter":0.020714,"FiveDayReturnBefore":0.03792},{"Ticker":"MYL","EffectiveDate":"2013-02-28","Type":"RatingNeutral","Title":"Goldman Sachs maintains MYL to Buy. Target Price is $33; previously $32.","DailyReturn":0.036402,"FiveDayReturnAfter":0.078399,"FiveDayReturnBefore":-0.004887},{"Ticker":"MYL","EffectiveDate":"2013-02-27","Type":"EarningBeat","Title":"After market close, MYL reports 2012 Q4's earning $0.65 per share and revenue $1720MM. This beats analyst's estimated EPS $0.64, meets estimated revenue $1720MM.","DailyReturn":0.008472,"FiveDayReturnAfter":0.080015,"FiveDayReturnBefore":-0.027159},{"Ticker":"MYL","EffectiveDate":"2013-01-08","Type":"RatingNeutral","Title":"Morgan Stanley downgrades MYL to Equal-Weight from Overweight; previously $27.","DailyReturn":-0.004658,"FiveDayReturnAfter":-0.013345,"FiveDayReturnBefore":0.036116},{"Ticker":"MYL","EffectiveDate":"2012-11-28","Type":"RatingNeutral","Title":"Canaccord Genuity maintains MYL to Buy. Target Price is $31; previously $30.","DailyReturn":-0.000368,"FiveDayReturnAfter":0.00696,"FiveDayReturnBefore":0.047432},{"Ticker":"MYL","EffectiveDate":"2012-11-26","Type":"RatingNeutral","Title":"Bank of America initiates coverage on MYL to Overweight.","DailyReturn":-0.004426,"FiveDayReturnAfter":0.002579,"FiveDayReturnBefore":0.061226},{"Ticker":"MYL","EffectiveDate":"2012-11-16","Type":"RatingUpgrade","Title":"Leerink Swann upgrades MYL to Outperform from Market Perform.","DailyReturn":0.001569,"FiveDayReturnAfter":0.061226,"FiveDayReturnBefore":-0.005866},{"Ticker":"MYL","EffectiveDate":"2012-10-26","Type":"RatingUpgrade","Title":"Canaccord Genuity upgrades MYL to Buy from Hold. Target Price is $30; previously $25.","DailyReturn":0.0088,"FiveDayReturnAfter":0.03305,"FiveDayReturnBefore":0.035419},{"Ticker":"MYL","EffectiveDate":"2012-07-26","Type":"EarningsRevenueBeat","Title":"Before market open, MYL reports 2012 Q2's earning $0.6 per share and revenue $1690MM. This beats analyst's estimated EPS $0.55, beats estimated revenue $1660MM.","DailyReturn":0.04887,"FiveDayReturnAfter":0.056465,"FiveDayReturnBefore":-0.038884},{"Ticker":"MYL","EffectiveDate":"2012-06-07","Type":"RatingNeutral","Title":"Bank oferica maintains MYL to Buy. Target Price is $27; previously $26.","DailyReturn":0.000936,"FiveDayReturnAfter":-0.024154,"FiveDayReturnBefore":-0.007458},{"Ticker":"MYL","EffectiveDate":"2012-04-26","Type":"EarningsRelease","Title":"Before market open, MYL reports 2012 Q1's earning $0.3 per share and revenue $1583MM..","DailyReturn":-0.003153,"FiveDayReturnAfter":-0.035767,"FiveDayReturnBefore":-0.013868}];